Daniel Fernandes Saragiotto

Pregabalin for the Prevention of Oxaliplatin-Induced Painful Neuropathy: A Randomized, Double-Blind Trial

Daniel Ciampi de Andrade, Manoel Jacobsen Teixeira, Ricardo Galhardoni et al. · The Oncologist · 2017 · 71 citations · Full text

Medicine, Oncology, Pharmacology +17

Randomized Phase III Trial Exploring the Use of Long-Acting Release Octreotide in the Prevention of Chemotherapy-Induced Diarrhea in Patients With Colorectal Cancer: The LARCID Trial

Paulo M. Hoff, Daniel Fernandes Saragiotto, Carlos H. Barrios et al. · Journal of Clinical Oncology · 2014 · 48 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Modified FLOX as first-line chemotherapy for metastatic colorectal cancer patients in the public health system in Brazil: Effectiveness and cost-utility analysis

Daniela Ribeiro Nebuloni, Milena Perez Mak, Fabiano Hahn Souza et al. · Molecular and Clinical Oncology · 2012 · 23 citations · Full text

Medicine, Oncology, Pharmacoeconomics +15

Malignant paratesticular mesothelioma

Leonardo Gomes da Fonseca, Daniel Fernandes Marques, Tiago Kenji Takahashi et al. · Autopsy and Case Reports · 2014 · 13 citations · Full text

Medicine, Oncology, Surgery +9

Safety and Efficacy of a Modified FLOX Adjuvant Regimen for Patients With Stage III Colorectal Cancer Treated in the Community

Bruno Mendonça Protásio, Adriana Reis Brandão Matutino, Liana Valente Lage et al. · Clinical Colorectal Cancer · 2016 · 12 citations · Full text

Medicine, Oncology, Chemotherapy +9